Tanco's got some interesting catalysts on the horizon that are hard to ignore for example, they are expanding into the healthcare sector through its indirect subsidiary Herbitec (M) Sdn Bhd, which is undertaking clinical trials for a plant-based product namedNoden™ as a potential treatment for dengue fever

January 12, 2026 Major shareholder executed substantial share transactions (approximately 13 million shares purchased & 8.99 million shares sold)

On January 5, Tanco saw high trading volume (approximately 74.86 million shares traded), making it one of the day's most actively traded stocks. The share price fluctuated around the RM1.18 level throughout the session.